J Biol Chem, Vol. 274, Issue 36, 25651-25658, September 3, 1999
The p185neu-containing Glycoprotein Complex of a
Microfilament-associated Signal Transduction Particle
PURIFICATION, RECONSTITUTION, AND MOLECULAR ASSOCIATIONS WITH
p58gag AND ACTIN*
Yongqing
Li
,
Fang
Hua
,
Kermit L.
Carraway§, and
Coralie A. Carothers
Carraway
¶
From the Departments of
Biochemistry and Molecular
Biology and § Cell Biology and Anatomy, University of Miami
School of Medicine, Miami, Florida 33101
 |
ABSTRACT |
Microfilaments associate with the microvillar
membrane of 13762 ascites mammary adenocarcinoma cells via a large
transmembrane complex (TMC) comprising the major glycoproteins
TMC-gp120, -110, -80, -65, and -55, the receptor kinase
p185neu, and the cytoplasmic proteins actin and p58gag,
linking the receptor with microfilaments in a signal transduction particle. Immunoblot screening with polyclonal antisera to TMC glycoproteins showed selective epithelial expression in normal rat
tissues and epithelially derived tumor cells. The TMC glycoproteins were isolated by solubilization of microfilament core preparations in
SDS, dilution, and separation on a concanavalin A-agarose affinity column. The large p185neu-containing complex was reconstituted
from the column eluate after displacement of SDS with nonionic
detergent, demonstrated by gel filtration and co-immunoprecipitation of
the glycoproteins with anti-gp55 or anti-p185neu. Exhaustive
biotinylation of the glycoproteins gave a stoichiometry of
gp120:gp110:gp80:gp65:gp55 of approximately 1:1:1:0.5:1. Overlay blots
with biotinylated actin and in vitro translated,
[35S]methionine-labeled p58gag, respectively,
showed specific interactions of actin with gp55 and gp120 and of
p58gag with gp65 and gp55. These results provide evidence for a
specific complex of microfilament-associated glycoproteins containing
p185neu and p58gag and suggest a role for the complex
in signal transduction scaffolding.
 |
INTRODUCTION |
The organization and reorganization of cell surface proteins play
critical roles in a multitude of cellular activities. These include
initiation of membrane polarity and cell morphogenesis, motility,
endocytosis, exocytosis, immune recognition and response, and cell-cell
and cell-matrix interactions. Surface protein organization can be
controlled by interactions of membrane proteins with extracellular components and with cytoplasmic cytoskeletal elements, particularly microfilaments (1, 2). Membrane-microfilament interaction sites play
important roles both in anchorage for the filaments (reviewed in Refs.
3 and 4) and in the transduction of extracellular signals to the
cytoplasm (5, 6). An emerging paradigm for sites of
membrane-microfilament interaction describes these sites as complexes
of membrane and cytoplasmic proteins, which are assembled and
associated, at least transiently, with cytoskeletal and signaling proteins (6). The sizes and relative stabilities of the complexes depend in part on the receptor and may be transient, as with growth factor receptor stimulation, or more stable, as in cell-cell
interaction sites.
The integral membrane component is in some cases relatively simple, as
for the integrins, heterodimeric
- and
-receptors that link cells
to extracellular matrix and to microfilaments (7-10). Through their
cytoplasmic domains, integrins provide the organizing site for membrane
cytoplasmic complexes, which contain numerous peripheral membrane
components, including several that interact with microfilaments
(9, 11, 12). Adherens junctions contain cadherin-catenin complexes (13,
14) linked to microfilaments. Cadherin is involved in the intercellular
interactions at cell junctions through
Ca2+-dependent homophilic associations (13, 15,
16). Its cytoplasmic domain is associated with a complex of
-,
-,
and
-catenins (17, 18), the last of which binds to microfilaments
(19). In both of these cases tyrosine kinases and other signaling
proteins have been localized to these membrane-microfilament
interaction sites.
In other cases, glycoprotein multimers provide the docking sites for
cytoskeletal or membrane skeletal proteins. For example, in the
neuromuscular junction a major membrane-microfilament interaction site
is the acetylcholine receptor, a multimeric integral membrane protein
complex that forms a ligand-activated ion channel (20-23). The
multimeric dystrophin-associated glycoprotein complex in muscle cells
(24) provides a site for interaction with microfilaments (25). The
dystrophin-glycoprotein complex containing four integral mem- brane
glycoproteins is also linked to the ion channel to form more complex
structures in neuromuscular junctions (26). This complex is associated
with a peripheral membrane glycoprotein
-dystroglycan (27), which in
the neuromuscular junction is a receptor for agrin, an
extracellular matrix protein that promotes clustering of the
acetylcholine receptor (28-30). Multisubunit receptors of the immune
system, including the T cell antigen receptor, the B cell antigen
receptor, and the high affinity receptor for immunoglobulin E, form
associations with the cytoskeletal matrix upon cell activation
(reviewed in Ref. 31). In each of these examples, microfilaments are
attached to a transmembrane complex containing multiple integral
membrane protein subunits.
In microvilli (32) from the aggressive 13762 ascites rat mammary
adenocarcinoma (33), a large, multimeric glycoprotein-containing TMC1 (34, 35) provides a
docking site for microfilaments and other cytoplasmic proteins. The TMC
is a major membrane-microfilament interaction site in the abundant
microvilli of the ascites cells (34). The core of the complex is a
large transmembrane glycoprotein complex (35) stably associated with
actin and a 58-kDa cytoplasmic protein (p58) previously implicated in
cell surface stability (36, 37) and xenotransplantability (33).
Purified p58 bound both to microfilaments in the manner of a capping
protein and to phospholipids (38). Because the cytoplasmic protein was
not required for the binding of the glycoproteins to actin, we
postulated that the glycoprotein-actin interaction is direct (34, 35). Complete cDNA sequencing of p58 characterized it as a truncated retroviral Gag-like protein lacking the nucleic acid-binding domain (39). Transfection of p58gag into COS-7 cells disrupted
microfilament organization (39), consistent with its proposed role in
altering morphology. p58gag contains PXXP motifs
implicated in Src homology 3 domain binding (40), binds to and
activates c-Src via its Src homology 3 domain and is phosphorylated by
c-Src (41).
The TMC glycoprotein complex, which comprises the core or scaffolding
of the membrane-microfilament interaction site in the ascites
microvilli, contains at least five major membrane glycoproteins, with
molecular masses of 120, 110, 80, 65, and 55 kDa (35). Additionally, it
contains the (proto)oncogene receptor p185neu/ErbB2 (42), which
has been implicated in both mitogenesis and differentiation (reviewed
in Ref. 43) in epithelial cells and is overexpressed in many human
breast cancers (44). The presence of the receptor kinase as well as the
cytoplasmic tyrosine kinases p60c-src and c-Abl
(45) in stable association with microvillar microfilaments via
interaction with the TMC suggested that this large complex serves as a
microfilament-linked, plasma membrane signal transduction particle
(42). The TMC glycoproteins have been purified by gel filtration as a
high Mr glycoprotein complex from detergent
lysates of either microvillar membranes or microfilaments extracted
under high pH, high salt conditions (35). In the present work, we report a new isolation method for the TMC-gps in which the
glycoproteins of the complex are separated by ConA affinity
chromatography after complete dissociation under denaturing conditions
from p60src, c-Abl (45), and other cytoplasmic membrane
skeletal and signaling proteins (57). We demonstrate that the
p185neu-containing glycoprotein complex can be reconstituted
and use this preparation for reconstitution studies to analyze specific interactions of the TMC-gps with the other major components of the TMC,
actin and p58gag. The results are consistent with our
hypothesis that the TMC-gps are the core of a stable organization site
for microfilaments at the membrane in the microvilli (34). As such, the
glycoprotein complex can be viewed as another class of scaffolding
protein (46) involved in the organization of signaling proteins.
Further, the following paper (57) describes the association of the
components of the Ras to mitogen-activated protein kinase mitogenic
pathway with this p185neu-containing TMC, supporting our
suggestion that this major membrane-microfilament interaction site is a
signal transduction particle (42) in the constitutively activated 13762 ascites mammary tumor cells (45).
 |
EXPERIMENTAL PROCEDURES |
Cell Growth and Isolation of Microvilli and Microvillar
Fractions--
MAT-C1 subline cells of the 13762 ascites rat mammary
adenocarcinoma were grown by intraperitoneal injection of 1.0-1.5 × 106 cells in 0.1-0.3 ml of 0.9% NaCl into
60-90-day-old female Fischer 344 rats (36). Cells were collected from
the peritoneal cavity after 7 days, washed with ice-cold PBS, and
resuspended in PBS. Microvilli were isolated by gently shearing the
cells through a 14-gauge needle, and the cell bodies were removed by
centrifugation at 2,500 × g for 5 min (32, 47). The
microvilli in the supernatant were obtained by differential
centrifugation at 20,000 × g for 30 min and washed
twice with PBS (47). Microfilament cores were prepared by extraction of
microvilli in a microfilament-stabilizing buffer (TPK buffer; 0.2%
Triton, 100 mM KCl, 2 mM MgCl2, 0.1 mM phenylmethylsulfonyl fluoride, and 20 mM
PIPES, pH 6.8) for 15 min and centrifugation at 15,000 × g for 15 min (48). Reconstituted TMC (rTMC) was prepared
from microfilament cores as described previously (35, 38). Briefly,
microfilament cores were solubilized in high salt (1 M KCl)
buffer at 4 °C for 2.5 h to depolymerize actin and release
actin-associated proteins. The extract was centrifuged at 100,000 × g, and the supernatant was dialyzed against isotonic (100 mM KCl) buffer overnight at 4 °C. The resulting
reassociated TMC complex was pelleted by centrifugation at 100,000 × g for 1.5 h to yield a sedimentable complex
containing predominantly actin, p58gag, and the TMC glycoproteins.
Preparation of Polyclonal Antisera to TMC-gp Complex and TMC-gp55
and Antibody Screening of Cells and Tissues--
Antisera were
prepared using two different sources of TMC glycoprotein. The first was
the early TMC-gp complex peak from Sephacryl S-1000 gel filtration
(42), which was solubilized in SDS, lyophilized, and reconstituted in
Freund's complete adjuvant prior to injection into rabbits. The
animals were boosted four times at 2-3-week intervals with 150-200
µg of protein prior to screening against TMC-gp-enriched microvillar
fractions. In the second method, ConA affinity-purified TMC-gps from
the glycoprotein-enriched rTMC were fractionated by SDS-PAGE. The gel
was stained briefly with Coomassie Blue, and the bands were excised and
eluted from the gel, mixed with Freund's complete adjuvant, and
injected into mice. After four or five boosts at 2-3-week intervals,
immunoblotting on microvilli and microvillar fractions was performed
with the resulting mouse polyclonal antiserum to determine the titer
and specificity of the antibody. For production of mouse polyclonal antisera to TMC-gp55 the ConA-agarose-purified TMC-gps were separated on SDS-PAGE, and TMC-gp55 was excised from the gel. The TMC-gp55 gel
band (10-40 µg) was homogenized in 0.9% NaCl and injected into the
peritoneal cavity of BALB/c mice, and booster injections were made at
2-week intervals. After the fifth boost (total of ~150 µg of
TMC-gp55 injected), the mice were bled, and anti-TMC-gp55 antibody was
detected by screening against the ConA-Sepharose-purified TMC-gps. For
screening by immunoblot, cells and cell fractions were solubilized in
electrophoresis buffer and separated by SDS-PAGE. For tissue screening,
rat tissues were removed and frozen in liquid nitrogen prior to
homogenization in buffer containing protease inhibitor mixture (42).
The homogenates were solubilized by boiling in SDS sample buffer, and
the proteins were separated on SDS-PAGE and transferred to
nitrocellulose membranes for immunoblotting, as described previously
(42, 49).
Purification of TMC-gps by Concanavalin A Affinity
Chromatography--
Microfilament core or reconstituted TMC was
solubilized in 2% SDS, boiled for 5 min, diluted to 0.05% SDS, and
incubated with ConA-Sepharose (Sigma) overnight at 4 °C. The
Sepharose suspension was packed into a column and washed with 20 bed
volumes of 0.05% SDS in 20 mM TES, pH 7.8. The
glycoproteins were eluted from the column with 1 ml of the
same buffer containing 0.3 M
-methylmannoside.
Reconstitution of TMC-gp Complex and Analysis of
Components--
For reconstitution of the complex, PBS containing
Triton X-100 was added to give a final Triton concentration 5 times the concentration of SDS. After incubation at 4 °C overnight, the TMC-gp
complex (about 80 µg of protein) was analyzed by Sephadex G-500 gel
filtration in PBS or by immunoprecipitation with anti-p185neu.
For analysis by gel filtration, the ascites cells were initially metabolically labeled with [14C]glucosamine as described
previously for the detection of glycosylated proteins (35). The bound
fraction from the ConA column containing TMC-gp's from either
microfilament core or rTMC was incubated in PBS with or without
Triton-100 and loaded onto a Sephadex G-500 column (1.0 × 95 cm)
equilibrated with 0.05% Triton in PBS. Fractions were eluted with the
same buffer. Aliquots of column fractions were assayed for the
glycoproteins by scintillation counting for radioactivity. The
14C-containing fractions were subjected to SDS-PAGE and
transferred to nitrocellulose for analysis by ConA blotting (35, 50). For immunoprecipitation with anti-p185neu, aliquots of
reconstituted or unreconstituted TMC-gp complex from ConA-Sepharose
were mixed with protein A-Sepharose beads and either 1 µg of
anti-p185neu (Ab 3, Oncogene Research Products, Cambridge, MA)
or 1.5-3 µg of normal mouse serum and incubated overnight at
4 °C. Immunoprecipitates were washed with PBS and eluted from the
beads with SDS electrophoresis sample buffer. The immunoprecipitates
were analyzed by anti-p185neu, anti-gp55, and ConA blots.
Stoichiometric Analysis of TMC Glycoproteins by
Biotinylation--
Reconstituted TMC in SDS was biotinylated by
treatment with 0.1 mM
N-hydroxysuccinimidylbiotin (water-soluble biotin; Pierce) for 2 h before loading onto the ConA affinity column. The
separated flow-through and bound fractions were fractionated by
SDS-PAGE, transferred to nitrocellulose membranes, and blocked with 5%
skim milk. The membranes were incubated with avidin-horseradish
peroxidase, and stained bands were detected using the
RenaissanceTM chemiluminescence assay kit (NEN Life Science Products).
Analysis of Actin Binding Proteins by Blot Overlay with
Biotinylated Actin (50, 51)--
Actin was purified from rabbit muscle
by the method of Pardee and Spudich (52). Biotinylated actin was
prepared by the method of Okabe and Hirokawa (53). Actin (25 mg)
polymerized in 100 mM KCl, 2 mM
MgCl2, 1 mM ATP, 0.1 mM
CaCl2, 10 mM Tris-HCl, pH 7.5, at 25 °C for
10 min was incubated with 8 mg of
N-hydroxysuccinimidylbiotin (at a concentration of 100 mg/ml
in Me2SO) for 10 min. The labeling reaction was quenched by
the addition of 100 mg of sodium glutamate, and the biotinylated
F-actin was isolated by centrifugation at 150,000 × g
for 90 min at 4 °C. The pellet was resuspended and depolymerized in
2 ml of 2 mM Tris-HCl, pH 7.5, 0.1 mM
CaCl2, 0.5 mM ATP, 0.2 mM
dithiothreitol. After two cycles of polymerization-depolymerization, the biotinylated actin pellet was resuspended in 2 mM
Tris-HCl, pH 7.5, 0.1 mM ATP and dialyzed against the same
buffer overnight. The G-actin was clarified by centrifugation at
100,000 × g for 5 min, frozen in aliquots in liquid
nitrogen, and stored at
80 °C. TMC-gp and flow-through fractions
from the ConA affinity fractionation of microfilament cores were
subjected to SDS-PAGE and transferred to an Immobilon polyvinylidene
difluoride membrane. The membrane was incubated at room temperature
with gentle rocking in denaturation buffer containing 7 M
guanidine-HCl, 50 mM TES (pH 8.3), 2 mM EDTA,
50 mM dithiothreitol for 1 h and in renaturation
buffer (50 mM TES, 100 mM KCl, 0.5 mM dithiothreitol, 2 mM EDTA, 1% bovine serum
albumin, 0.1% Nonidet P-40, pH 7.5) at 4 °C overnight. The membrane
was blocked with 5% bovine serum albumin in 30 mM TES, pH
7.5, 120 mM KCl at room temperature for 1 h and
incubated with biotinylated actin in actin polymerization buffer (plus
0.02% Triton) at 4 °C overnight. After three washes in 30 mM Tris (pH 7.5), 120 mM NaCl, 0.05% Tween 20 and two washes in 30 mM Tris (pH 7.5), 120 mM
NaCl, the blot was incubated with avidin conjugated to horseradish
peroxidase at room temperature for 2 h and developed with
4-chloro-1-naphthol.
Binding of [35S]Methionine-labeled, in Vitro
Translated p58gag to TMC Glycoproteins--
In
vitro translation of p58gag was performed as described
previously (39) using the TNT Coupled Reticulocyte Lysate System (Promega, Madison, WI) according to the manufacturer's instructions. Briefly, DNA template of p58gag (2 µg/50-µl reaction) was
mixed with 25 µl of reticulocyte lysate, 40 units of RNasin
inhibitor, 40 µCi of [35S]methionine (Amersham
Pharmacia Biotech), amino acid mixture minus methionine, and T7 RNA
polymerase. The reaction mixture was incubated at 30 °C for 2 h, and the product was analyzed by SDS-PAGE and autoradiography.
Reconstituted TMC-gp, obtained by Triton treatment of the eluted
fraction from the ConA affinity column, was incubated with the in
vitro-translated p58gag in PBS containing 0.05% Triton at
4 °C overnight. After centrifugation at 10,000 × g
for 10 min, the supernatant of the mixture was incubated with protein
A-Sepharose beads and either 1.5-2 µg of anti-gp55 antibody or
1.5-3 µg of normal mouse serum at 4 °C overnight. Immunoprecipitates were washed with PBS and analyzed by SDS-PAGE and autoradiography.
 |
RESULTS |
Preparation of TMC-gps by ConA Affinity Chromatography--
As a
first approach toward understanding the structure and interactions of
proteins in the large, microfilament-associated transmembrane complex,
we initiated studies to dissociate and reconstitute the signal
transduction particle components. This approach was complicated by the
major difficulty that the stability of the complex resulted in the
co-purification of cytoplasmic proteins, including c-Src and c-Abl (45)
and sometimes actin and associated proteins (35). Attempts to purify
the glycoproteins under various conditions short of denaturing
conditions were unsuccessful. To assure the removal of actin and other
tightly associated components, the starting material (microfilament
cores or other TMC-enriched fraction) was first solubilized in SDS.
Since the TMC-gps are ConA-binding proteins (35), ConA affinity
chromatography was then used in a one-step purification method, which
greatly improved the yield. The SDS concentration after solubilization
was diluted to 0.05%, which prevents reassociation of the
glycoproteins and other components and does not interfere with
glycoprotein binding to the ConA-agarose.
For these preparations, any TMC-enriched fraction can serve as starting
material (35, 42). Fig. 1 shows a
comparison of the results starting with the largest TMC-containing
fraction, the microfilament core, and the rTMC, a more highly purified
fraction obtained by high salt extraction of the microfilament core
(35, 38). Analysis by SDS-PAGE shows that all of the proteins readily detected by Coomassie Blue were eluted in the flow-through, while the
entire complement of TMC-gps, which stain poorly with protein stains
(35), was eluted by
-methylmannoside from the bound fraction. When
ConA-binding proteins from unfractionated microvilli were
affinity-purified by this method, the bound fraction contained glycoproteins other than those associated with microfilaments, including the major ascites cell ConA-binding membrane protein ASGP-2
(37). Immunoblots of the bound fractions with antisera to purified
TMC-gp55 showed a band having the same electrophoretic mobility as the
ConA-staining band previously identified as TMC-gp55. Anti-p185neu immunoblotting (Fig. 1, last
panel) showed that the TMC-gp-associated (proto)oncogene
product tyrosine kinase receptor p185neu (45) is also found in
the ConA-bound fraction from SDS-solubilized STP-containing fractions,
consistent with the observation by Lin and Clinton (54) that this
growth factor receptor is a ConA-binding glycoprotein.

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 1.
Isolation of TMC-gps from reconstituted TMC
by ConA affinity chromatography in SDS. Microfilament cores and
rTMC were solubilized in SDS, diluted, and applied to ConA affinity
columns as described under "Experimental Procedures." Starting
material, unbound (flow-through) fraction, and bound fraction eluted
with -methylmannoside were assayed by Coomassie Blue staining and
ConA blotting. Immunoblotting with antibodies to p185neu and
TMC-gp55 was also performed on rTMC and its unbound and bound
fractions.
|
|
Antibodies against TMC-gps--
For investigations of this
glycoprotein complex and its functions, we have prepared polyclonal
antibodies to different glycoprotein preparations. Antibodies were made
in rabbits to the entire TMC-gp complex using TMC-gp complex prepared
by the high salt, high pH gel filtration method (35). A comparison of
the immunoblot analysis with the ConA blot of TMC-gp complex purified
on ConA-agarose (Fig. 2A)
showed that these antisera bound primarily to TMC-gp55 and TMC-gp65,
the only proteins detected by the antisera in isolated microvilli (data
not shown). The other TMC-gps of the complex elicited a weak
immunogenic response, which required further boosts to detect (data not
shown). Immunoblot analyses of several rat tissues with the anti-TMC-gp
complex antisera (Fig. 2B and Table I) and with antisera made in mice against
blot-purified TMC-gp-65 and -55 (Table I) showed the preferential
expression of these two glycoproteins in epithelial tissues. Further,
they were also found in varying levels in tumor cell lines derived from
epithelia, but not in fibroblasts (Table I). An apical localization was suggested by their abundant expression in brush borders isolated from
rat intestinal preparations (data not shown). These results indicate
that at least TMC-gp65 and TMC-gp55 are expressed in normal epithelial
tissues and suggest that the TMC may play a role in epithelial cell
organization.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 2.
Reactivity of purified TMC-gps and normal rat
tissues with TMC-gp polyclonal antisera. A, immunoblot
analysis of purified TMC-gps from the MAT-C1 adenocarcinoma purified on
ConA-agarose. B, immunoblot analysis of normal rat tissue
extracts.
|
|
Stoichiometry of the Major Glycoproteins in the TMC and TMC-gp
Complex--
One of the problems in analyzing the TMC and TMC-gps has
been that the glycoproteins stain very poorly with Coomassie Blue (Ref.
35; Fig. 1). Coomassie staining of gels of TMC isolated from
Triton-solubilized microvillar membranes by velocity sedimentation sucrose density gradient centrifugation showed predominantly actin and
p58gag. Metabolic labeling with leucine, on the other hand,
showed a more nearly stoichiometric relationship between actin,
p58gag, and glycoprotein (34). Metabolic labeling with
[14C]glucosamine (35), as well as ConA blots from the
same preparations (35), detected five glycoproteins in the complex.
Several approaches were attempted to establish the stoichiometric
relationships among the major components of the TMC. Other protein
stains were less effective than Coomassie Blue in staining the
glycoproteins. Silver staining resulted in extraction of the
glycoproteins from the gels, as previously noted (35). The metabolic
labeling procedure used in the early studies suffered from the drawback
that incorporation was low and varied among the glycoproteins with time
of incorporation of label (data not shown). Biotinylation gave the most
reproducible results. ConA-agarose-purified TMC-gps from microfilament
cores were biotinylated and analyzed by Coomassie Blue gel, ConA blot, and a blot of the biotinylated glycoproteins detected with
avidin-horseradish peroxidase (Fig. 3).
The glycoproteins stained poorly with the protein stain (Fig.
3A) but were readily visualized with ConA (Fig.
3B). A comparison of the ConA blot with the biotinylation blot (Fig. 3C) showed that gp55 and gp45 were detected more
efficiently by ConA than by biotinylation, probably because of the
differences in amounts of N-linked carbohydrate among the
glycoproteins. Notably, p185neu was readily detected by
biotinylation, although only weakly detected by ConA. Because a
significant amount of ASGP-2, the transmembrane subunit of rat
sialomucin complex (Muc-4) (120-140 kDa), remains associated with
microfilament cores (35, 49), a more highly purified TMC-gp complex
preparation was treated in the same manner for quantification. A
TMC-gp-enriched fraction reconstituted after a high salt extraction of
microfilament cores (rTMC; Refs. 35 and 38) was analyzed to determine
the relative amounts of the individual TMC-gps. The approximate ratios
obtained from these analyses were as follows: gp120/110, 1; gp80, 1;
gp65, 0.5; gp55, 1. Quantification of an equivalent amount of
biotinylated flow-through material (data not shown) gave a relative
value of 1 for p58gag. Actin was variable in the rTMC, ranging
from 2 to 6 in different rTMC preparations. Quantification from several
experiments gave approximately the same ratios, with some variation in
the relative amounts of gp80 and gp65 retained after the high salt
extraction procedure. Notably, the relative amount of p185neu
remaining associated with the TMC-gps was 0.8-1.5. The biotinylation method shows clearly that the TMC contains similar amounts of p58gag and the TMC-gps rather than the much greater amount of
p58gag shown by protein staining. Thus, the TMC contains
sufficient amounts of the TMC-gps to serve as a scaffolding with which
other components of the TMC can associate.

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 3.
Analysis of purified TMC glycoproteins by
biotinylation. Microfilament (MF) cores and rTMC were
fractionated by ConA affinity chromatography, and the bound fractions
were biotinylated and analyzed as described under "Experimental
Procedures."
|
|
Reassociation of Purified TMC-gps and p185neu--
One
of the aims in generating a highly purified TMC-gp preparation was to
obtain the glycoprotein complex for reconstitution studies to generate
the putative signal transduction particle. Such reconstitution studies
require reassociation of the TMC-gps, the putative core of the signal
transduction particle, and their formation of a complex with
p185neu. The glycoprotein fraction eluted from the ConA column
was subjected to treatment with buffers containing nonionic detergent
to displace SDS bound to the proteins. The optimal reconstitution
conditions consisted of overnight treatment with PBS containing a
5-fold excess of Triton X-100 to displace SDS. Two types of analyses were used to demonstrate reconstitution. In the first, reconstituted and unreconstituted metabolically labeled TMC-gp complex were compared
by gel filtration. The column profiles of the glucosamine-labeled glycoproteins showed that reconstituted TMC-gp complex eluted as a
discrete peak near the void volume of the Sephacryl S-500 column, while
the unreconstituted glycoproteins eluted much later (Fig.
4A). ConA blots and anti-gp55
blots of reconstituted (Fig. 4B) and unreconstituted (Fig.
4C) TMC-gps revealed the individual glycoproteins eluting
with each.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 4.
Sephacryl S-500 analysis of unreconstituted
and reconstituted ConA-purified TMC-gps.
p185neu-containing TMC-gps were isolated from the microvillar
microfilament core from [14C]glucosamine-labeled ascites
cells by ConA affinity chromatography as in Fig. 1. Aliquots of the
eluted bound fraction were dialyzed against 0.05% SDS and incubated
without or with a 5-fold excess of Triton X-100 in isoionic buffer. The
unreconstituted and reconstituted TMC-gp complex-containing samples
were fractionated on a Sephacryl S-500 column and analyzed by
scintillation counting. A, [14C]glucosamine
profiles; B, ConA blot of reconstituted complex;
C, ConA blot of unreconstituted complex.
|
|
In the second type of analysis, the reconstituted TMC-gp complex was
immunoprecipitated with anti-p185neu, and the
immunoprecipitates were analyzed by SDS-PAGE and immunoblotting with
anti-p185neu, anti-gp55, and ConA. As shown in Fig.
5, all of the glycoprotein components in
the reconstituted TMC-gp complex were immunoprecipitated with
anti-p185neu, indicating that they had reassociated into a
complex that binds p185neu. In the unreconstituted purified
TMC-gps, the TMC-gps were not co-precipitated. None of the
glycoproteins in either mixture was immunoprecipitated by nonimmune
mouse serum. Co-immunoprecipitation of p185neu with the
reconstituted glycoprotein complex was also observed if
immunoprecipitation was performed with anti-gp55, and the
immunoprecipitate was assayed by immunoblotting with
anti-p185neu (data not shown). These results indicate that
p185neu binds directly to the TMC-gp complex without a
requirement for actin, although they do not rule out additional direct
binding of p185neu to microfilaments.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 5.
Immunoprecipitation of reconstituted TMC-gp
complex with anti-p185neu. Reconstituted complex prepared
as described in the legend to Fig. 3 was immunoprecipitated with
anti-p185neu or nonimmune serum. The immunoprecipitates were
assayed by immunoblotting with anti-p185 and anti-gp55 and ConA
blotting. Lanes 1, immunoprecipitation with
nonimmune serum; lanes 2, immunoprecipitation
with anti-p185neu.
|
|
Association of Actin with TMC-gps--
One of the primary proposed
functions of the TMC-gp complex is the association with microfilaments.
We have previously shown that the complex partially purified by high
salt, high pH gel filtration reassociates with actin during
polymerization. To determine whether the reconstituted purified TMC-gp
complex will bind microfilaments, Triton-treated fractions from the
ConA column were incubated with actin under polymerizing conditions and
sedimented under conditions that sediment microfilaments associated
with the glycoprotein complex but not unassociated microfilaments or
glycoprotein unattached to the microfilaments (35). The pellet was
analyzed by SDS-PAGE and blotting with ConA and anti-p185neu.
Actin co-sedimented with the glycoprotein complex and p185neu
when it was polymerized in the presence of the complex but not in its
absence (Fig. 6). Likewise, the
glycoprotein complex, including p185neu, was sedimented with
polymerized actin, but not in its absence.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 6.
Association of reconstituted TMC-gp complex
with polymerized actin. TMC-gp glycoproteins eluted from
ConA-agarose were reconstituted into a complex as described. The
reconstituted complex was incubated with actin under polymerizing
conditions and centrifuged as described under "Experimental
Procedures." The pellets were analyzed by SDS-PAGE followed by
Coomassie Blue staining and blotting with ConA and
anti-p185neu.
|
|
An overlay procedure with biotinylated actin was used to investigate
the association of specific glycoprotein(s) with actin. By this method,
the predominant actin-binding protein observed was gp55 (Fig.
7). Lesser binding to gp120 and to a band
of about 180 kDa was observed. Binding to all was abolished in the
presence of excess unlabeled actin. These results suggest that gp55 and perhaps other members of the TMC-gp complex may serve as binding sites
for microfilaments at the membrane. The identity of the ~180-kDa
protein is not known with certainty, but preliminary studies suggest
that it may be
p185neu.2

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 7.
Detection of actin binding to specific TMC
glycoproteins by biotinylated actin overlay analysis. TMC-gp
complex from microfilament (MF) core, eluted from
ConA-agarose, was run on SDS-PAGE and assayed by Coomassie staining. A
second set of samples from the same gel were transferred to
nitrocellulose for actin overlay assay. Biotinylated actin was
incubated with the blot in the absence or presence of excess unlabeled
actin. The biotinylated actin bound to the blot was visualized with
streptavidin-horseradish peroxidase as described.
|
|
Association of p58gag with TMC-gps--
In previous
studies, we have shown that in vitro translated
p58gag associates with the TMC during reconstitution from high
salt buffer (42). To determine whether p58gag binds directly to
the TMC-gps as well as to microfilaments, ConA-purified TMC-gps were
reconstituted into a complex in Triton and incubated with the
35S-labeled p58gag translation mixture (39).
Immunoprecipitation of the incubation mixture with anti-TMC-gp55, but
not nonimmune serum, and assay by immunoblotting with anti-p58 and
anti-p185neu demonstrated the association of the p58gag
with the TMC-gps (Fig. 8). Overlay
analysis of the purified TMC-gps using 35S-labeled
p58gag showed that p58gag associated with TMC-gp65 and
TMC-gp55 (Fig. 9). Binding was competed by an excess of unlabeled p58gag.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 8.
Association of in vitro translated p58gag with TMC-gps. Reconstituted TMC-gp
complex was incubated with in vitro-translated,
35S-labeled p58gag prepared as described previously
(39). The incubation mixture was immunoprecipitated with anti-gp55, and
the immunoprecipitates (imppts.) were analyzed for
p58gag by fluorography and by immunoblotting with
anti-p185neu and ConA blotting for the TMC-gps.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 9.
Overlay analysis of binding of p58gag
to TMC-gps. A blot of ConA-agarose-purified TMC-gps was incubated
with in vitro translated, 35S-labeled
p58gag in the absence and presence of excess purified
p58gag.
|
|
 |
DISCUSSION |
Early studies on microvilli of the MAT-C1 ascites subline of the
13762 rat mammary adenocarcinoma focused on delineating the molecular
mechanisms for interactions of microfilaments with the membrane.
Subsequent studies identified a large, stable,
microfilament-associated glycoprotein complex that was
characterized as a major membrane-microfilament interaction site in the
microvilli (34, 35, 42, 45, 47). It became clear upon further
characterization of the complex (35, 41, 42) that it was a signaling
complex as well as a membrane-microfilament interaction site. The
ultimate objective was to characterize the components and interactions
of a "minimal" TMC, taking the approach of systematically
increasing the stringency of the extraction buffers. High salt
treatment removed many of the membrane skeletal proteins but was
inadequate for completely removing membrane (nonfilamentous) actin and
other cytoplasmic proteins, including c-Src (35). Ultimately,
denaturing conditions were required for complete dissociation of the complex.
The present study was directed toward a basic understanding of the
interactions among the major components of this critical interaction
site: the TMC-gps, p58gag, and actin (see Fig.
10). To address the question of the
organization of the TMC, we have begun a series of studies to
reconstitute the TMC-gp as a core on which to build a functional
complex. For reconstitution, the most important step was the
purification of the core glycoproteins. The use of ConA affinity
chromatography in SDS is ideal because it combines complete
dissociation of the glycoproteins from associated components with a
rapid, specific, and high yield method of isolation. Most importantly,
the glycoproteins reform the complex after displacement of SDS by
nonionic detergent, and p185neu reassociates with the
reconstituted glycoprotein complex. The composition and stoichiometry
of the reconstituted complex are not discernibly different from that
isolated from microvillar fractions. This reconstitution study provides
further evidence for the TMC-gp complex as a discrete entity and for
the avidity of its association with p185neu. Further, we have
demonstrated functionality of the reconstituted complex in two ways. 1)
The reconstituted TMC-gp complex binds F-actin in a
polymerization/sedimentation assay, as previously shown for the less
highly purified complex isolated by gel filtration (35). These results
provide further support for our proposal that the TMC-gp complex is a
microfilament association site that may be involved in the dynamics of
cellular actin. 2) The reconstituted TMC-gp complex binds in
vitro translated p58gag, as previously demonstrated for
p58gag displaced from the TMC and reconstituted from high salt
buffers (38). Blot overlay studies define the major components of actin binding/polymerization in the TMC-gp to be TMC-gp120 and TMC-gp55, with
other possible associations, including p185neu. In some TMC-gp
preparations, a large glycoprotein having an Mr
in the tyrosine kinase receptor range also exhibits actin binding. Previous studies have shown that F-actin binds to the epidermal growth
factor receptor at a site in its cytoplasmic domain similar to a
peptide of profilin (56). Since the cytoplasmic domain of
p185neu contains a peptide of similar sequence, this epidermal
growth factor receptor family member may also bind F-actin. Studies are under way to determine whether this protein is actually p185neu
and, if so, whether the variability in binding may be a function of the
phosphorylation state of the receptor. Multiple associations of
membrane components of complexes with microfilaments have also been
observed in focal adhesion complexes (9), which may also be sites of
integration of signals.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 10.
Model for p185neu-containing TMC-gp
complex association with actin and p58gag. MF,
microfilament.
|
|
However, the TMC is more than just a microfilament attachment site at
the membrane, as indicated by its strong association with the receptor
kinase p185neu (42) and with p60src and c-Abl (45). The
observation that the cells contain constitutively tyrosine-phosphorylated proteins, including p58gag, suggested
that the growth factor receptor is constitutively activated (45). This
activation has been proposed to occur by an ascites cell integral
membrane ligand ASGP-2, which selectively binds ErB2 and modulates
ErbB2/ErbB3 responsiveness to NDF/heregulin (55). From these collective
studies, we have proposed that the TMC acts as a signal transduction
particle that can regulate the association of microfilaments at the
membrane and integrate signals from different pathways.
These findings and proposals raise two major questions. 1) Are the TMC
glycoproteins components of normal cells? 2) How is the TMC organized
to allow it to function as a regulatory site in the cell membrane?
Immunoblot analyses on normal rat tissues with antibodies to the
TMC-gps clearly show the presence of TMC-gp55 and TMC-gp65, apparently
the most immunogenic of the TMC-gps, in tissues that contain epithelia,
but not in nonepithelial tissues. Further, they are found in intestinal
brush border preparations, suggesting an apical localization. These
results, in combination with our studies on the tumor cells, suggest
that the TMC-gp complex may play a role in the generation and/or
maintenance of polarity in epithelial cells.
A major question largely unelucidated in studies of cell regulation is
that of the molecular mechanisms involved in mediating the pleiotypic
effects on a cell as a consequence of growth factor binding,
e.g. cytoskeletal reorganization. Localization of signaling elements at the membrane-microfilament interface would position them
strategically for integrating changes in gene expression with the
global structural alterations in the cell that must occur prior to and
during mitogenesis. We envision that the TMC glycoproteins serve as a
microfilament-associated scaffolding that can integrate signals
impinging on the normal epithelial cell. Major signals include growth
modulators and interactions of the cell with both matrix components and
with adjacent cells. We propose that signals mediated by integrins,
cadherin, and growth factor receptors, all of which associate with
microfilaments, may be integrated via selective associations with the
TMCs. In malignantly transformed cells, the pleiotypic alterations
observed on cell properties encompass numerous pathways, many known to
involve interactions with microfilaments. We further hypothesize that
in tumor cells disruption of signal integration involves a
reorganization of the TMC's and their associated microfilaments,
permitting re-localization of receptors. This redistribution of
signaling proteins and their associated microfilament assemblies
contribute to the coordinated loss of normal epithelial polarity,
cell-cell and cell-matrix interactions, gene transcription, and
metabolic functions of all types.
Recent experiments have shown that several of the TMC-gps, including
gp55, can be phosphorylated.2 Thus, microfilament dynamics
may be directly regulated by phosphorylation of the glycoproteins.
Tyrosine phosphorylation site(s) may also recruit kinases that have Src
homology 2 domains, such as Src, to the TMC-gp, where they could
phosphorylate the glycoproteins. The association of phosphorylated
p185neu and other phosphorylated components in the TMC leads to
its second potential function, as a signal transduction particle. We
have recently demonstrated the association with the TMC of all of the components of the Ras/mitogen-activated protein kinase mitogenesis pathway (companion paper). In addition to p60c-src
and c-Abl (45), other signaling elements, such as protein kinase C,
phospholipase C
, and the p85 subunit of phosphatidylinositol 3-kinase3 are also associated
with the TMC. These results suggest that the TMC glycoproteins may
serve a scaffolding role, not only in the organization of individual
signal transduction pathways, such as the mitogenesis pathway, but also
in the integration of different pathways. The isolation of the
TMC-gp-p185neu complex provides a starting point for
biochemical and molecular biological approaches to elucidating
mechanisms for the formation and functions of some of these regulatory complexes.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants GM 33795 and CA72577.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Biochemistry and Molecular Biology R-629, University of Miami School of
Medicine, Miami, FL 33101. Tel.: 305-243-5759; Fax: 305-243-4431; E-mail: ccarrawa@mednet.med.miami.edu.
2
Y. Li, unpublished observation.
3
M. E. Carvajal, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
TMC, transmembrane
complex;
TMC-gp, transmembrane complex glycoprotein;
ConA, concanavalin
A;
PBS, phosphate-buffered saline (Dulbecco's, no Ca2+);
PIPES, piperazine-N,N'-bis(2-ethanesulfonic acid);
rTMC, reconstituted transmembrane complex;
PAGE, polyacrylamide
gel electrophoresis;
STP, signal transduction particle;
TES, N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic
acid.
 |
REFERENCES |
| 1.
|
Stossel, T. P.
(1989)
J. Biol. Chem.
264,
18261-18264[Free Full Text]
|
| 2.
|
Stossel, T. P.
(1993)
Science
260,
1086-1094[Abstract/Free Full Text]
|
| 3.
|
Carraway, K. L.,
and Carraway, C. A. C.
(1989)
Biochim. Biophys. Acta
988,
147-171[Medline]
[Order article via Infotrieve]
|
| 4.
|
Luna, E. J.,
and Hitt, A. L.
(1992)
Science
258,
955-964[Abstract/Free Full Text]
|
| 5.
|
Carraway, C. A. C.,
and Carraway, K. L.
(1996)
in
Treatise on the Cytoskeleton
(Hesketh, H. E.
, and Pryme, I. F., eds), Vol. 2
, pp. 207-238, JAI Press Inc., Greenwich, CT
|
| 6.
|
Carraway, K. L.,
Carraway, C. A. C.,
and Carraway, K. L., III
(1998)
Signaling and the Cytoskeleton
, Springer-Verlag, Berlin
|
| 7.
|
Fox, J. E.
(1993)
Adv. Exp. Med. Biol.
344,
75-85
|
| 8.
|
Sobue, K.
(1993)
Neurosci. Res.
18,
91-102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Lo, S. H.,
and Chen, L. B.
(1994)
Cancer Metastasis Rev.
13,
9-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Rosales, C.,
O'Brien, V.,
Kornberg, L.,
and Juliano, R.
(1995)
Biochim. Biophys. Acta
1242,
77-98[Medline]
[Order article via Infotrieve]
|
| 11.
|
Yamada, K. M.,
and Miyamoto, S.
(1995)
Curr. Opin. Cell Biol.
7,
681-689[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Richardson, A.,
and Parsons, J. T.
(1995)
BioEssays
17,
229-236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Kemler, R.,
Ozawa, M.,
and Ringwald, M.
(1989)
Curr. Opin. Cell Biol.
1,
892-897[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Takeichi, M.
(1991)
Science
251,
1451-1455[Abstract/Free Full Text]
|
| 15.
|
Nagafuchi, A.,
Tsukita, S.,
and Takeichi, M.
(1993)
Semin. Cell Biol.
4,
75-81
|
| 16.
|
Grunwald, G. B.
(1993)
Curr. Opin. Cell Biol.
5,
797-805[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Gumbiner, B. M.
(1996)
Cell
84,
345-357[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Kemler, R.
(1993)
Trends Genet.
9,
317-321[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Rimm, D. L.,
Koslov, E. R.,
Kebriaei, P.,
Cianci, C. D.,
and Morrow, J. S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8813-8817[Abstract/Free Full Text]
|
| 20.
|
Pumplin, D. W.,
and Bloch, R. J.
(1993)
Trends Cell Biol.
3,
113-117
[CrossRef][Medline]
[Order article via Infotrieve] |
| 21.
|
Froehner, S. C.
(1993)
Annu. Rev. Neurosci.
16,
347-368[Medline]
[Order article via Infotrieve]
|
| 22.
|
Bloch, R. J.,
and Randall, W. R.
(1994)
Curr Biol.
4,
936-938[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Apel, E. D.,
and Merlie, J. P.
(1995)
Curr. Opin. Neurobiol.
5,
62-67[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Sunada, Y.,
and Campbell, K. P.
(1995)
Curr. Opin. Neurol.
8,
379-384[Medline]
[Order article via Infotrieve]
|
| 25.
|
Ervasti, J. M.,
and Campbell, K. P.
(1991)
Cell
66,
1121-1131[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Campbell, K. P.
(1995)
Cell
80,
675-679[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Apel, E. D.,
Roberds, S. L.,
Campbell, K. P.,
and Merlie, J. P.
(1995)
Neuron
15,
115-126[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Matsumura, K.,
and Campbell, K.
(1994)
Muscle Nerve
17,
2-15[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Sealock, R.,
and Froehner, S. C.
(1994)
Cell
77,
617-619[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Gee, S. H.,
Montanaro, F.,
Lindenbaum, M. H.,
and Carbonetto, S.
(1994)
Cell
77,
675-686[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Caplan, S.,
and Baniyash, M.
(1995)
Immunol. Res.
14,
98-118[Medline]
[Order article via Infotrieve]
|
| 32.
|
Carraway, K. L.,
Huggins, J. W.,
Cerra, R. F.,
Yeltman, D. R.,
and Carraway, C. A. C.
(1980)
Nature
285,
508-510[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Howard, S. C.,
Hull, S. R.,
Huggins, J. W.,
Carraway, C. A. C.,
and Carraway, K. L.
(1982)
J. Natl. Cancer Inst.
69,
33-40
|
| 34.
|
Carraway, C. A. C.,
Jung, G.,
and Carraway, K. L.
(1983)
Proc. Natl. Acad. Sci.
80,
430-434[Abstract/Free Full Text]
|
| 35.
|
Carraway, C. A. C.,
Hua, F.,
Ye, X.,
Juang, S.-H.,
Liu, Y.,
Carvajal, M.,
and Carraway, K. L.
(1991)
J. Biol. Chem.
266,
16238-16246[Abstract/Free Full Text]
|
| 36.
|
Carraway, K. L.,
Doss, R. C.,
Huggins, J. W.,
Chesnut, R. W.,
and Carraway, C. A. C.
(1979)
J. Cell Biol.
83,
529-543[Abstract/Free Full Text]
|
| 37.
|
Huggins, J. W.,
Trenbeath, T. P.,
Yeltman, D. R.,
and Carraway, K. L.
(1980)
Exp. Cell Res.
127,
27-46
|
| 38.
|
Liu, Y.,
Carraway, K. L.,
and Carraway, C. A. C.
(1989)
J. Biol. Chem.
264,
1208-1214[Abstract/Free Full Text]
|
| 39.
|
Juang, S.-H.,
Huang, J.,
Li, Y.,
Salas, P.,
Fregien, N.,
Carraway, C. A. C.,
and Carraway, K. L.
(1994)
J. Biol. Chem.
269,
15067-15075[Abstract/Free Full Text]
|
| 40.
|
Feller, S. M.,
Ren, R.,
Hanafusa, H.,
and Baltimore, D.
(1994)
Trends Biochem. Sci.
19,
453-458[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Huang, J.,
Zhang, B.-T.,
Li, Y.,
Juang, S.-H.,
Mayer, B. J.,
Carraway, K. L.,
and Carraway, C. A. C.
(1999)
Oncogene
18,
4099-4107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Carraway, C. A. C.,
Carvajal, M. E.,
Li, Y.,
and Carraway, K. L.
(1993)
J. Biol. Chem.
268,
5582-5587[Abstract/Free Full Text]
|
| 43.
|
Carraway, K. L., III,
and Cantley, L. C.
(1994)
Cell
78,
5-8[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Slamon, D. J.,
Godolphin, W.,
Jones, L. A.,
Holt, J. A.,
Wong, S. G.,
Keith, D. E.,
Levin, W. J.,
Stuart, S. G.,
Udove, J.,
Ullrich, A.,
and Press, M. F.
(1989)
Science
244,
707-712[Abstract/Free Full Text]
|
| 45.
|
Juang, S.-H.,
Carvajal, M. E.,
Whitney, M.,
Liu, Y.,
and Carraway, C. A. C.
(1996)
Oncogene
12,
1033-1042[Medline]
[Order article via Infotrieve]
|
| 46.
|
Faux, M. C.,
and Scott, J. D.
(1998)
Cell
85,
9-12
|
| 47.
|
Carraway, C. A. C.,
Cerra, R. F.,
Bell, P. B.,
and Carraway, K. L.
(1982)
Biochim. Biophys. Acta
719,
126-139[Medline]
[Order article via Infotrieve]
|
| 48.
|
Carraway, C. A. C.,
Jung, G.,
Hinkley, R. E.,
and Carraway, K. L.
(1985)
Exp. Cell Res.
157,
71-82[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Vanderpuye, O.,
Carraway, C. A. C.,
and Carraway, K. L.
(1988)
Exp. Cell Res.
178,
211-223[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Carraway, C. A. C.
(1992)
in
The Cytoskeleton: A Practical Approach
(Carraway, K. L.
, and Carraway, C. A. C., eds)
, pp. 123-150, IRL Press, Oxford
|
| 51.
|
Snabes, M. C.,
Boyd, A. E., III,
and Bryan, J.
(1983)
Exp. Cell Res.
146,
63-70[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Pardee, J. D.,
and Spudich, J. A.
(1982)
J. Cell Biol.
93,
648-654[Abstract/Free Full Text]
|
| 53.
|
Okabe, S.,
and Hirokawa, N.
(1989)
J. Cell Biol.
109,
1581-1595[Abstract/Free Full Text]
|
| 54.
|
Lin, Y. Z.,
and Clinton, G. M.
(1991)
Oncogene
6,
639-643[Medline]
[Order article via Infotrieve]
|
| 55.
|
Carraway, K. L., III,
Rossi, E. A.,
Komatsu, M.,
Price-Schiavi, S. A.,
Huang, D.,
Guy, P. M.,
Carvajal, M. E.,
Fregien, N.,
Carraway, C. A. C.,
and Carraway, K. L.
(1999)
J. Biol. Chem.
274,
5263-5266[Abstract/Free Full Text]
|
| 56.
|
den Hartigh, J. C.,
van Bergen en Henegouwen, P. M. P.,
Verkleij, A. J.,
and Boonstra, J.
(1992)
J. Cell Biol.
119,
349-355[Abstract/Free Full Text]
|
| 57.
|
Carraway, C. A. C.,
Carvajal, M. E.,
and Carraway, K. L.
(1999)
J. Biol. Chem.
274,
25659-25667[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea